Sort
23,748 grants matching “melanoma”
Community Outreach and Engagement
$140,368Chau Trinh-Shevrin · New York University School Of Medicine · P30 · FY2020 · CA
Developmental Research Program
$140,308Walter J Storkus · University Of Pittsburgh At Pittsburgh · P50 · FY2011 · CA
Administrative Equipment Supplement for GM135160
$140,220Stephanie Gupton · Univ Of North Carolina Chapel Hill · R35 · FY2020 · GM
Core 1: Microfabication
$140,211Rong Fan · Yale University · U54 · FY2019 · CA
MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS
$140,208Wistar Institute · R21 · FY2000 · CA
Coded-aperture Compton scatter imaging for real-time tumor motion tracking during ablative radiotherapy
$140,148Bernard L Jones · University Of Colorado Denver · R21 · FY2022 · CA
Clinical development of a blood based assay that detects the BRAF V600E mutation in melanoma and thyroid cancer patients
$140,135Ryan J Sullivan · Massachusetts General Hospital · UH2 · FY2018 · CA
GENETIC ANALYSIS TECHNIQUES FOR COMMON CANCERS
$140,130Nicola J Camp · University Of Utah · K07 · FY2007 · CA
Development of Novel Markers for Melanoma Progression
$140,130Byungwoo Ryu · Johns Hopkins University · K01 · FY2006 · CA
GENETIC ANALYSIS TECHNIQUES FOR COMMON CANCERS
$140,130Nicola J Camp · University Of Utah · K07 · FY2008 · CA
Data-driven mechanistic models of morphology-controlled Ras oncogenic signaling
$140,097Hanieh Mazloom Farsibaf · Ut Southwestern Medical Center · K99 · FY2025 · CA
Administrative Core
$140,097Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA
Beyond Lysis: Deciphering the Role of Perforin-Mediated Ferroptosis in Anti-Tumor Immunity
$139,968Hannah Noelle Bell · University Of Michigan At Ann Arbor · K99 · FY2025 · CA
SMC/MUC4-ErbB2 Complex: Implications on Neoplasia
$139,933Victoria P Ramsauer · East Tennessee State University · K01 · FY2007 · CA
Prognostic Significance and Targeting of an iNOS-Associated Human Melanoma
$139,875Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
$139,821Leslie Bernstein · Beckman Research Institute/City Of Hope · K05 · FY2013 · CA
Core B: Biostatistics and Bioinformatics
$139,710Chengcheng Hu · University Of Arizona · P01 · FY2021 · CA
HUMAN IMMUNOLOGIC MONITORING
$139,619Thomas F Gajewski · University Of Chicago · P30 · FY2010 · CA
Project 1: Mutation-specific vulnerabilities for KRAS-targeted therapy
$139,601Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
Targeted Polymer Micelles for Treatment of Metastatic Melanoma
$139,587Kevin N Sill · Intezyne Technologies, Llc · R41 · FY2013 · CA
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
$139,569Leslie Bernstein · Beckman Research Institute/City Of Hope · K05 · FY2011 · CA
Development of therapeutic monoclonal antibody to the bioactive lipid lysophospha
$139,523Rosalia Gerarda Matteo · Lpath Therapeutics, Inc. · R43 · FY2009 · CA
A plasticity and reprogramming paradigm for therapy resistance at the single cell level
$139,492Arjun Raj · University Of Pennsylvania · U01 · FY2019 · CA
Regulators of Translation Elongation Factor eEF1A
$139,422Terri Goss Kinzy · Rbhs-Robert Wood Johnson Medical School · R01 · FY2017 · GM
Core B: Biostatistics and Bioinformatics
$139,382Chengcheng Hu · University Of Arizona · P01 · FY2023 · CA